Israel Orija, MD
NPI 1790780278 · Endocrinology, Diabetes & Metabolism Physician · Austell, GA
Enrolled with Medicare as Practitioner - Endocrinology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1790780278
- Entity type
- Individual
- Primary specialty
- Endocrinology, Diabetes & Metabolism PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- 054859 (GA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
3 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
204 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 139 | $128 |
| Blood Glucose (sugar) Test Performed By Hand-Held Instrument82962 | 65 | $3 |
Typical Medicare-allowed amounts for these services range $3–$128 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, not a price quote and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 55 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Semaglutidebrand: Ozempic | 273 | 55 |
| Levothyroxine Sodium | 168 | 42 |
| Atorvastatin Calcium | 138 | 48 |
| Empagliflozinbrand: Jardiance | 116 | 27 |
| Dulaglutidebrand: Trulicity | 99 | 21 |
| Tirzepatidebrand: Mounjaro | 92 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$23 across 1 record (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (2)
- 285 Boulevard NeSte 525Atlanta, GA 30312-4205Phone: (404) 265-1044Fax: (404) 265-1047
- 315 Boulevard NeSte 200Atlanta, GA 30312-1220Phone: (404) 265-4644Fax: (404) 265-1190
Registry dates
- Enumerated
- 2005-06-20
- Last updated
- 2022-10-31
- Certified
- 2022-10-31
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.